CP-866087 - An Overview
bortezomib will raise the level or result of flibanserin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. Enhanced flibanserin adverse outcomes may happen if coadministered with several weak CYP3A4 inhibitors.B: Can be suitable. Either animal studies show no threat but human scientific studies not accessible or animal re